China Universal Asset Management Company’s Inhibrx, Inc. Common Stock INBX Stock Holding History

China Universal Asset Management Company’s Portfolio INBX Stock Details INBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-9,106	Closed	-$318K	–	452
2024 Q1	$318K	Buy	9,106 +3,635	+66%	+$133K	0.04%	235
2023 Q4	$208K	Buy	5,471 +4,354	+390%	+$93.3K	0.04%	201
2023 Q3	$20.5K	Buy	1,117 +545	+95%	+$11.4K	0.01%	295
2023 Q2	$14.8K	Sell	572 -18	-3%	-$420	﹤0.01%	293
2023 Q1	$11.1K	Buy	590 +148	+33%	+$3.44K	﹤0.01%	284
2022 Q4	$10.9K	Buy	442 +77	+21%	+$2.26K	﹤0.01%	221
2022 Q3	$7K	Buy	+365	New	+$6.58K	﹤0.01%	244

Other funds holding INBX

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

China Universal Asset Management Company's INBX Position: Q2 2024 in Review

China Universal Asset Management Company sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2024, closing a stake of 9,106 shares — an estimated $318K sold.

China Universal Asset Management Company first reported a position in INBX in Q3 2022 and held it in 7 quarters. The position peaked at $318K in Q1 2024. 2 funds tracked by Wall St. Rank hold INBX as of Q2 2024.

China Universal Asset Management Company reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
China Universal Asset Management Company sold 9,106 Inhibrx, Inc. Common Stock shares in Q2 2024, an estimated $318K.
China Universal Asset Management Company first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
China Universal Asset Management Company's Inhibrx, Inc. Common Stock position peaked at $318K in Q1 2024.
2 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2024.

Based on China Universal Asset Management Company's 13F filing for Q2 2024, filed 19 Jul 2024.